Syncona Limited (SYNC) Ordinary NPV

Sell:100.40pBuy:101.20p0.80p (0.80%)

FTSE 250:0.75%
Market closed |
Prices delayed by at least 15 minutes
Sell:100.40p
Buy:101.20p
Change:0.80p (0.80%)
Market closed |
Prices delayed by at least 15 minutes
Sell:100.40p
Buy:101.20p
Change:0.80p (0.80%)
Market closed |
Prices delayed by at least 15 minutes

Trust Information

About this company

Syncona Limited is a Guernsey-based closed-ended investment company. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. The Company invests in life science businesses (including private and quoted companies) and single or multi-asset projects. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership), in which the Company is the sole limited partner. Syncona Investment Management Limited is its investment manager.

Objective

The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects. The Company targets an annualised return per share across its investment portfolio of 15 per cent per annum over the long term.

Costs

  • Ongoing charge1.93%
  • Annual management charge -
  • Performance feeNo

Fee structure

The company will pay SIML an annual fee

Value Assessment

  • Value Assessment review date31 March 2024
  • Value Assessment next review date-
  • Is Assessment of Value required under COLL?No
  • Outcome of COLL Assessment of Valuen/a
  • Outcome of PRIN Value Assessment or reviewProduct expected to provide fair value for reasonably foreseeable period
  • Other review related to value and or charges -
  • Further information-
Click to see more

Key facts

  • Currency
    GBX
  • Benchmark
    FTSE 250 TR GBP
  • Shares in issue
    647.96m
  • Gross gearing
    0.00%
  • EPIC
    SYNC
  • ISIN
    GG00B8P59C08
  • Domicile
    Guernsey
  • Exchange
    London Stock Exchange (LON)
  • Index
    FTSE All Share Index, Britain-FTSE250-Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview of the company, currency, shares in issue, EPIC, location, exchange, index, website, Data sourced by LSEG. Objective, Costs, Fee Structure, Key facts including Benchmark, Gross gearing are provided by MorningStar.